The Beef on Selective Androgen Receptor Modulators (SARM)

The Beef on Selective Androgen Receptor Modulators (SARM) Josh Baker, MD In 1999, Ligand Pharmaceuticals created something new. A drug that mimicked testosterone, but was more selective for skeletal muscle than previous versions of androgens. In their pursuit to treat muscle wasting in patients with cancer they developed what is known today as nonsteroidal selective …

Read More